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Abstract
Introduction: Cardiopulmonary bypass (CPB) surgery is considered one of the
most frequent surgical procedures in which acute kidney injury (AKI) represents
a frequent and serious complication. The aim of the present study was to eval-
uate the efficiency of neutrophil gelatinase-associated lipocalin (NGAL) as an
early AKI biomarker after CPB in pediatric cardiac surgery.
Material and methods: The study included forty children aged 2 to 78 months
undergoing CPB. They were divided into group I: patients who suffered AKI
grades II and III; and group II: patients who did not develop AKI or at risk. Periph-
eral venous blood was withdrawn pre- and post-operatively for serial measure-
ments of NGAL and creatinine. Statistical analysis was performed using Statis-
tical Package for Social Sciences version 14.
Results: Mean plasma NGAL levels showed highly significant elevations in group I
patients at 2, 12, and 24 h after surgery (p < 0.0001) compared to group II. Sig-
nificant correlations were found between NGAL and creatinine at different time
intervals. Highly significant correlations (p < 0.0001) were found between 
plasma NGAL and AKI at 2, 12 and 24 h after surgery. A cut-off level of 100 ng/ml
at 2 h, and 125 ng/ml at 12 h post-operatively both recorded the highest accu-
racy, being 95% accurate, with sensitivity of 100% and 89.5% respectively, and
specificity of 90.5% and 100% respectively.
Conclusions: This study showed that plasma NGAL could be used as an early
biomarker for detection of AKI following CPB. We recommend further studies
on a wider scale to validate the current study results. 
Key words: neutrophil gelatinase-associated lipocalin, biomarker, acute kidney
injury, cardio-pulmonary bypass, pediatrics.
Introduction
Acute kidney injury (AKI) is a term proposed to reflect the entire spec-
trum of acute renal failure (ARF), a complex disorder that occurs in a wide
variety of settings with clinical manifestations ranging from minimal ele-
vation in serum creatinine to anuric renal failure [1]. In 2004, a consensus
definition for AKI was proposed by the Acute Dialysis Quality Initiative:
the RIFLE criteria (risk, injury, failure, loss, end-stage renal disease) [2]. The
adult-derived RIFLE definition was modified, and then applied and vali-
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dated in pediatric patients and renamed as the
pediatric RIFLE (pRIFLE) criteria. Pediatric RIFLE 
stratifies AKI from mild (RIFLE: R, risk) to severe
(RIFLE: F, failure) based on changes in serum crea-
tinine or estimated creatinine clearance (eCCl) and
urine output. The first study that defined AKI using
the pRIFLE criteria found that AKI occurred in 82%
of the most critically ill children admitted to a pedi-
atric intensive care unit (PICU) [3].
The AKI represents a significant problem in clin-
ical medicine, with devastating immediate and
long-term consequences [4, 5]. The incidence of AKI
varies from 5% of hospitalized patients to 30% of
patients in intensive care units. Cardiopulmonary
bypass (CPB) surgery is considered one of the most
frequent major surgical procedures performed
worldwide [6], in which AKI represents a frequent
and serious complication in about 30-50% of
patients [7]. The AKI requiring dialysis occurs in up
to 5% of these cases, in whom the mortality rate
approaches 80% [8].
Diagnosis and management of AKI constitutes
one of the most important roles of the pediatric
nephrologist in an intensive care unit (ICU) [9].
In current practice, AKI is typically diagnosed by
measuring serum creatinine, which is a reliable
marker of kidney function. Unfortunately, its con-
stant and slow production makes its rise small and
late in the case of acute injury. There remains
a need for a much earlier marker in order to diag-
nose AKI as soon as possible [10].
Neutrophil gelatinase-associated lipocalin
(NGAL), a 25 kDa protein, is generally expressed in
very low concentrations in several human tissues,
and is greatly elevated in the case of epithelial dam-
age [11, 12]. In healthy kidneys, it is barely detectable
in either plasma or urine. However, in the setting
of acute tubular injury, NGAL undergoes rapid and
profound up-regulation with large increases in both
urine and plasma [13].
There are many ongoing studies to elucidate the
nature of the association between NGAL and AKI
in different critical care settings. This includes dif-
ferent types of cardiac surgery, contrast-induced
nephropathy, worsening renal function in patients
who suffer heart failure and sepsis.
The aim of the present study was to evaluate
the efficiency of NGAL plasma level as an early AKI
biomarker after CPB in pediatric cardiac surgery.
Material and methods
The present study was carried out in the cardio-
thoracic ICU, Children’s Hospital, Cairo University
and the Clinical Pathology Department of the
National Research Centre (NRC) during the period
from January 1st, 2010 to June 1st, 2010.
Forty children aged 2 to 78 months were enrolled
in the study. They underwent CPB for variable peri-
ods ranging from 10 up to 180 min depending on
the type of anomaly and procedure done, which
included surgical correction or palliation of con-
genital heart disease. Patients with pre-existing
renal insufficiency, or suffering from peripheral vas-
cular diseases, or on nephrotoxic drugs before sur-
gery, as well as known diabetics were excluded from
the study. The development of acute kidney injury
was assessed using the pediatric RIFLE classifica-
tion [2] (AKI grade I equivalent to RIFLE: risk, AKI
grade II equivalent to RIFLE: injury, AKI grade III
equivalent to RIFLE: failure). Informed consent from
the patients' caregivers was obtained and approved
by the Ethical Committee of the NRC and Cairo Uni-
versity Children's Hospital.
Patients included in the study were subjected to
full history taking and thorough clinical examina-
tion focusing on blood pressure, central venous
pressure, urine output, and respiratory and venti-
latory support by assessment of fraction of inspired
oxygen and mean airway pressure recorded before
surgery and at 2, 12, and 24 h following surgery.
Laboratory investigations included complete
blood count (CBC) including white blood cell and
differential counts using ADVIA 60 (Bayer Diagnos-
tics, UK); assessment of renal functions by estima-
tion of serum levels of urea, creatinine, sodium,
potassium, calcium and phosphorus; serum albu-
min level (Synchron CX5 automated chemistry ana-
lyzer); blood gas analysis using Nova 9 (Nova Biome  -
dical, USA); blood cultures and sensitivity using Bactec
9050 (Becton Dickenson Diagnostic System, USA);
plasma NGAL levels using Human Lipocalin-2/NGAL
ELISA (BioVendor Research and Diagnostic Prod-
ucts, Czech Republic). Blood cultures and sensitiv-
ity tests were done for selected patients as clini-
cally indicated at any time of the study depending
on progression of the condition. Serum urea, crea-
tinine, sodium, potassium and plasma NGAL levels
were assessed preoperatively as well as at 2, 12 
and 24 h following surgery. 
Sampling
Preoperatively: 6 ml of peripheral venous blood
was withdrawn from every patient under complete
aseptic conditions, 3 ml of the withdrawn blood
was anticoagulated with EDTA for performing
quantitative measures of NGAL, and the rest was
left to clot at room temperature, then centrifuged
and sera were separated for assessment of urea,
creatinine, sodium, potassium, calcium, phospho-
rus and albumin.
Postoperatively: Monitoring of the patients was
accomplished by serial assessments of CBC, serum
urea, creatinine, sodium, potassium and plasma
NGAL; and 3 ml of arterial blood was withdrawn from
every patient through an inserted arterial cannula
and was added to heparinized tubes for assessment
of arterial blood gases as well as acid base status.
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Statistical analysis
The data were analyzed using Statistical Pack-
age for Social Sciences (SPSS) version 14. A p value
of < 0.05 was considered significant. Unpaired Stu-
dent's t-test was used to assess the statistical sig-
nificance of the difference between two population
means in a study involving independent samples.
The multiple regression test was used for assess-
ing multiple linear regressions aiming to find a lin-
ear relationship between a response variable and
several possible predictors. Correlation analysis was
used for assessing the strength of association
between two variables. The correlation coefficient
(r) defines the strength and direction of the linear
relationship between two variables. Cut-off levels
for sensitivity and specificity were determined using
χ2; Fisher exact test was performed in tables con-
taining a value less than 5. 
Results
The demographic data of the patients enrolled
in the present study are shown in Table I. Patients
were classified according to pediatric RIFLE criteria
(2) into: 1 – 8 patients (20%) with no evidence or
risk of AKI; 2 – 13 (32.5%) at risk for developing AKI
(AKI grade I equivalent to RIFLE: Risk); 3 – 15 (37.5%)
showing evidence of AKI without failure (AKI gra  de II
equivalent to RIFLE: Injury; and, 4 – 4 (10%) suffer-
ing from acute renal failure (AKI grade III equiva-
lent to RIFLE: Failure). For statistical reasons, the
patients were divided into two groups: group I:
patients who suffered AKI grades II and III (RIFLE:
Injury and Failure); group II: patients who did not
develop AKI or at risk (AKI grade I, RIFLE: Risk).
Comparison of serial plasma NGAL levels
between patients of group I versus patients of
group II is represented in Table II, and showed high-
ly significant elevations in mean plasma NGAL lev-
els in group I patients at 2, 12, and 24 h after sur-
gery (p < 0.0001). 
In Table III, significant correlations are shown
between NGAL and creatinine at different time inter-
vals, especially most evident at 12 and 24 h after sur-
gery. Figure 1 shows the correlation coefficient (r) of
plasma NGAL versus serum creatinine with acute kid-
ney injury at varying time intervals (2, 12, and 24 h
after surgery). Highly significant correlations 
(p < 0.0001) were recorded for plasma NGAL and AKI
at 2, 12 and 24 h after surgery (r = 0.893, r = 0.873,
and r = 0.795 respectively). However, for serum cre-
atinine, highly significant correlations with AKI were
delayed and existed at 12 and 24 h post-operatively
(0.609 and 0.711 respectively). Several cut-off levels
were analyzed to explore the sensitivity and speci-
ficity of plasma NGAL to detect AKI grades II and III.
A cut-off level of 100 ng/ml 2 h after surgery and 
125 ng/ml at 12 h after surgery both recorded the
highest accuracy, being 95% accurate, with sensitiv-
ity of 100% and 89.5% respectively, and specificity
of 90.5% and 100% respectively. 
Our results show that sepsis was significantly
evident in group I patients compared to group II 
(p = 0.034). Since it was observed that 72.5% of
cases (29 patients) showed evidence of sepsis, diag-
nosed by an increase in total leukocytic count num-
ber associated by evident shift of band cells to the
left during the first 48 h after surgery or by positive
Variable Patients (n = 40)
Age (mean ± SD) [months] 20.75 ±23.33
Sex (M/F) 20/20
Clinical diagnosis 
Large VSD [%] 40
TGA with VSD-ASD [%] 15
VSD-DORV [%] 12.5
ASD [%] 10
Others† [%] 22.5
Dialysis requirement, n (%)* 4 (10)
Non-survivors, n (%)** 9 (22.5)
*Patients were all males with cyanotic heart conditions, **6 patients
had multiple organ failure, 3 suffered from cardiovascular failure;
†include hypoplastic right ventricle with VSD and ASD; VSD-ASD with
patent ductus arteriosus; TGA without VSD
VSD – ventricular septal defect, TGA – transposition of great arteries,
ASD – atrial septal defect, DORV – double-outlet right ventricle
Table I. Demographic data of studied children
Plasma NGAL [ng/dl]G roup I Group II Value of p
AKI Grade II and III (n = 19) No AKI and AKI grade I (n = 21)
Mean SD Mean SD
Before surgery 42.58 ±16.51 36.17 ±15.12 0.2483
2 h after surgery 154.79 ±51.14 66.05 ±20.26 < 0.0001*
12 h after surgery 201.79 ±54.89 83.67 ±21.59 < 0.0001*
24 h after surgery 238.74 ±71.92 108.05 ±26.49 < 0.0001*
Table II. Comparison of serial plasma NGAL levels between patients of group I versus patients of group II
*Highly significant difference; NGAL – neutrophil gelatinase associated lipocalin, AKI – acute kidney injury
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culture results [14], we further explored the rela-
tionship between sepsis and NGAL. After excluding
cases with AKI grades II and III, we compared two
groups: the first one showing evidence of sepsis
versus the second group with no evidence of sep-
sis, as shown in Table IV. The difference between
the groups was non-significant.
Discussion 
Acute kidney injury, formerly known as acute
renal failure, continues to represent a very common
and potentially devastating problem in critically ill
children [15, 16]. Unfortunately, the mortality and
morbidity associated with AKI remain unacceptably
high, with mortality rates approaching 80% in crit-
ically ill children with multiple organ dysfunction
syndrome [17].
The association between cardiopulmonary
bypass and AKI is well recognized [18]. In current
clinical practice, AKI is typically diagnosed by meas-
uring an acute rise in serum creatinine. However, it
is well known that creatinine is an unreliable and
insensitive indicator during early, acute changes in
kidney function, as serum creatinine concentrations
typically do not change until approximately 50% of
kidney function has already been lost [19].
In the present work, plasma NGAL mean levels
were compared between group I (AKI grades II 
and III) and group II (no AKI and AKI grade I) 
(Table II). The results showed that there were high-
ly significant differences in plasma NGAL levels
between the groups; this significant difference start-
ed as early as 2 h after surgery (p < 0.0001), which
reflects the potential role of plasma NGAL as an ear-
ly biomarker in predicting AKI. The same results have
been confirmed in many studies [12, 20, 21]. 
The relationship between plasma NGAL and
serum creatinine levels, as well as the correlations
of each marker with AKI at different time intervals,
were studied (Table III, Figure 1).
Plasma NGAL levels were found to be signifi-
cantly correlated with both serum creatinine and
AKI at 2, 12 and 24 h after surgery, whereas serum
creatinine did not show a significant correlation
with AKI until after 12 h following surgery. 
Many studies have explored the relationship
between NGAL and AKI in children and adults. Zap-
pitelli et al. [12], in a study on critically ill pediatric
patients, found that NGAL concentrations in AKI
patients exhibited a six-fold increase in concentra-
tion that persisted from 48 h before to 48 h after
development of AKI, and concluded that NGAL
could serve well in predicting AKI before a rise in
serum creatinine becomes apparent. In 2008,
Devarajan [22] showed that plasma NGAL meas-
urements could represent an early biomarker of AKI
in the pediatric intensive care setting, being able
to predict this complication about 2 days prior to
the rise in serum creatinine with high sensitivity
Serum creatinine [mg/dl]P lasma NGAL [ng/dl]
Value of r Value of p
2 h after surgery 0.4758 0.0019
12 h after surgery 0.7194 < 0.0001*
24 h after surgery 0.8075 < 0.0001*
*Highly significant correlation
Table III. Correlation of plasma NGAL with serum cre-
atinine at 2, 12 and 24 h after surgery
Plasma NGAL [ng/dl]G roup I Group II Value of p
Evidence of sepsis (n = 12) No evidence of sepsis (n = 9)
Mean SD Mean SD
Before surgery 39.58 ±14.51 32.89 ±15.92 0.3281
2 h after surgery 63.08 ±18.26 70 ±23.18 0.4530
12 h after surgery 79.75 ±16.36 88.89 ±27.27 0.3501
24 h after surgery 102.33 ±27.2 115.67 ±24.97 0.2643
Table IV. Plasma NGAL mean levels in patients with sepsis versus patients without sepsis after excluding cases with
AKI grades II and III
1.0
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Figure 1. Correlation coefficient (r) of plasma NGAL
versus serum creatinine with acute kidney injury at
varying time intervals (2, 12, and 24 h after surgery)
NGAL – neutrophil gelatinase-associated lipocalin
V
a
l
u
e
 
o
f
 
r
Plasma NGAL          Serum creatinine254 Arch Med Sci 2, April / 2012
and area under the curve (AUC) values of 0.68-0.78.
The 2-h post-operative plasma NGAL levels strong-
ly correlated with the duration and severity of AKI
and length of hospital stay.
Figure 1 shows the trend of both biomarkers in
relation to AKI. Whereas plasma NGAL showed
a rapid early rise 2 h after surgery which persisted
until 12 h after surgery, with a slow decline there-
after, serum creatinine showed a slow rise which was
non-significant at 2 h but started to be significant at
12 h, with a further rise at 24 h after surgery. 
These recorded results reflect the nature of both
biomarkers. Regarding serum creatinine, it took
time to build up and that is why it became signifi-
cant as time passed. On the other hand, plasma
NGAL pumped up its level early when AKI devel-
oped, which is why it was gradually washed out of
the blood stream [23].
In order to explore the sensitivity and specifici-
ty of plasma NGAL level in predicting AKI grade II
and III (RIFLE: Injury and Failure), several cut-off val-
ues were analyzed. Plasma NGAL level of 100 ng/ml
at 2 h after surgery and 125 ng/ml at 12 h after sur-
gery both recorded the highest accuracy, being 95%
accurate. The sensitivity and specificity of plasma
NGAL cut-off value of 100 ng/ml at 2 h after sur-
gery were 100% and 90.48% respectively, while the
sensitivity and specificity of plasma NGAL cut-off
value of 125 ng/ml at 12 h after surgery were
89.47% and 100% respectively.
The previous results show that plasma NGAL lev-
el could be used for detection of AKI as early as 
2 h post-operatively and to confirm AKI at 12 h with
great accuracy and high sensitivity and specificity.
Our results were close to a collective data analy-
sis done in 2008 for some published performanc-
es of NGAL as a predictive biomarker for AKI, which
revealed mean AUC-ROC of 0.82; the mean derived
sensitivity and specificity from these studies were
in the 75-80% range [21, 22]. From the published
studies, the derived optimal cut-off value of NGAL
for the early prediction of AKI appeared to be at
a median value of approximately 150 ng/ml [22].
Finally, the current study showed that sepsis was
significantly evident in patients with AKI. Hence,
we concluded that sepsis is a potential risk factor
for developing AKI. Previous studies have mentioned
that plasma NGAL levels might be affected by sep-
sis [24, 25]. In a study by Bagshaw et al. [26], criti-
cally ill patients with septic AKI were associated
with significantly higher plasma NGAL at enrollment
compared with non-septic AKI. However, in the
present work, it seems that the levels of NGAL were
not affected by sepsis as they showed non-signifi-
cant differences between the group with sepsis ver-
sus the non-septic group after excluding the effect
of overt AKI.
In conclusion, in this study plasma NGAL levels
obtained at 2 h after surgery showed a highly sig-
nificant correlation with AKI, and this correlation
remained high until 24 h after surgery. Hence, plas-
ma NGAL could be used as an early biomarker for
diagnosis of AKI following CPB in pediatric cardiac
surgery. We recommend further studies on a wider
scale to validate the current study results. 
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